Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: Johns Creek, Georgia 25 trials found
New Search
Filter
Trial Phase
Study Type
Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers
PHASE2INTERVENTIONAL Atlanta, Georgia +4 more
RECRUITING
Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With Pembrolizumab
N/AOBSERVATIONAL Atlanta, Georgia
RECRUITING
Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers
PHASE2INTERVENTIONAL Atlanta, Georgia +4 more
RECRUITING
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
PHASE1, PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
PHASE3INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
PHASE2INTERVENTIONAL Berkeley, California +4 more
RECRUITING
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
PHASE3INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC
PHASE2INTERVENTIONAL Miami, Florida +2 more
RECRUITING
Personalized Vaccine Immunotherapy in Combination With Checkpoint Inhibitor for Treatment of Triple Negative Breast Cancer
PHASE1INTERVENTIONAL Atlanta, Georgia +3 more
RECRUITING
A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
PHASE2INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
ProAgio in Combination With Gemcitabine in Patients With Metastatic Triple Negative Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Atlanta, Georgia +1 more
RECRUITING
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
PHASE1INTERVENTIONAL Duarte, California +4 more
RECRUITING
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
PHASE3INTERVENTIONAL Daphne, Alabama +4 more
RECRUITING
High Dose Radiation Therapy With Pembrolizumab and Chemotherapy for the Treatment of Patients With PD-L1 Positive Metastatic Triple Negative Breast Cancer
PHASE2INTERVENTIONAL Atlanta, Georgia
RECRUITING
Acutherapy to Prevent Aromatase Inhibitor-Associated Arthralgias in Non-Hispanic Black Postmenopausal Women With Early-Stage Breast Cancer
NAINTERVENTIONAL Atlanta, Georgia +3 more
RECRUITING
Study of XB010 in Subjects With Solid Tumors
PHASE1INTERVENTIONAL Irvine, California +4 more
RECRUITING
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
PHASE1INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
PHASE1INTERVENTIONAL Little Rock, Arkansas +4 more
RECRUITING
Trial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.
PHASE1, PHASE2INTERVENTIONAL Phoenix, Arizona +4 more
RECRUITING
A First-in-Human Study of MEN2312 in Adults With Advanced Breast Cancer
PHASE1INTERVENTIONAL Springdale, Arkansas +4 more
RECRUITING
Trial of Trastuzumab Deruxtecan in Previously Treated HER2
PHASE2INTERVENTIONAL New Haven, Connecticut +2 more
RECRUITING
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
NAINTERVENTIONAL Atlanta, Georgia
RECRUITING
Filter Trials
Trial Phase
Study Type